Phys Written Answers · gastrointestinal
Chronic Pancreatitis — Written Clinical Reasoning
DCE long-case preparation: structured written reasoning for chronic pancreatitis — the irreversible fibroinflammatory definition (TIGAR-O), alcohol as the dominant cause with smoking as the key cofactor, the clinical triad of chronic pain, steatorrhoea from 90 per cent exocrine loss, and brittle type 3c diabetes, the investigations (faecal elastase below 200, CT calcification, MRCP, EUS Rosemont), the analgesic ladder and endoscopic-surgical drainage after Cahen, pancreatic enzyme replacement with a PPI, and pancreatic cancer surveillance. Also covers autoimmune (type 1, IgG4-related, steroid-responsive) and tropical calcific pancreatitis.
On this page
Study tools
Target exams
Chronic Pancreatitis — Written Clinical Reasoning
Part A — Diagnosis, aetiology and staging
Diagnosis
The diagnosis is chronic pancreatitis, established by the combination of characteristic clinical features (chronic recurrent epigastric pain radiating to the back, steatorrhoea, weight loss, and new-onset diabetes), objective exocrine insufficiency (faecal elastase 65 micrograms per gram, indicating severe insufficiency), and characteristic irreversible imaging (a dilated irregular main pancreatic duct with calcifications and parenchymal atrophy on CT). No further diagnostic testing is required to confirm the diagnosis in this advanced case. The 2016 mechanistic consensus defines chronic pancreatitis as a pathological fibroinflammatory syndrome of the pancreas producing irreversible structural damage with permanent loss of exocrine and endocrine function [1].
Aetiological framework — the TIGAR-O classification
The aetiology should be classified using the TIGAR-O mechanistic framework [2]. This patient's disease is toxic-metabolic, driven by chronic heavy alcohol use, with smoking as the likely cofactor (which must be asked about, as it independently accelerates fibrosis and markedly increases pancreatic cancer risk). The other categories — idiopathic, genetic (PRSS1, SPINK1, CFTR, CTRC), autoimmune (type 1 IgG4-related, type 2), recurrent and severe acute pancreatitis, and obstructive — should be considered if the alcohol history is uncertain or atypical features are present (young age, a positive family history, painless obstructive jaundice suggesting autoimmune pancreatitis). In this patient the alcohol history is sufficient, but I would check a lipid panel, calcium, and serum IgG4 to exclude coexistent hypertriglyceridaemia, hypercalcaemia, and autoimmune pancreatitis.
Staging
The disease is in the burnt-out (insufficiency) phase: the steatorrhoea and type 3c diabetes indicate that the gland has lost more than 90 per cent of its exocrine secretory capacity and a large proportion of its endocrine function. The pain may eventually abate as the parenchyma is destroyed, but at present it remains a major problem. [1]
References8ShowHide
- [1]Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition Pancreatology, 2016.PMID 26924663
- [2]Whitcomb DC Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers Clin Transl Gastroenterol, 2019.PMID 31166201
- [3]Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) United European Gastroenterol J, 2017.PMID 28344786
- [4]Ewald N, Hardt PD Diagnosis and treatment of diabetes mellitus in chronic pancreatitis World J Gastroenterol, 2013.PMID 24259958
- [5]Kirkegård J, Mortensen FV, Cronin-Fenton D Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis Am J Gastroenterol, 2017.PMID 28762376
- [6]Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology Pancreas, 2011.PMID 21412117
- [7]de la Iglesia-García D, Huang W, Szatmary P, et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis Gut, 2017.PMID 27941156
- [8]Cahen DL, Gouma DJ, Nio Y, et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis N Engl J Med, 2007.PMID 17301298